PepGen Inc. (PEPG)
2.36
-0.05
(-2.07%)
USD |
NASDAQ |
Oct 30, 16:00
2.345
-0.02
(-0.64%)
After-Hours: 20:00
PepGen Free Cash Flow : -69.46M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -69.46M |
| March 31, 2026 | -77.27M |
| December 31, 2025 | -81.90M |
| September 30, 2025 | -85.76M |
| June 30, 2025 | -90.60M |
| March 31, 2025 | -83.34M |
| December 31, 2024 | -82.87M |
| September 30, 2024 | -82.77M |
| Date | Value |
|---|---|
| June 30, 2024 | -75.28M |
| March 31, 2024 | -77.58M |
| December 31, 2023 | -71.60M |
| September 30, 2023 | -66.48M |
| June 30, 2023 | -71.17M |
| March 31, 2023 | -65.74M |
| December 31, 2022 | -63.02M |
| September 30, 2022 | -54.67M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Korsana Biosciences, Inc. | -4.517M |
| IRulya Therapeutics, Inc. | -47.00M |
| Q32 Bio, Inc. | -19.83M |
| Bridgebio Oncology Therapeutics, Inc. | -193.82M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.81M |
| Cash from Investing (Quarterly) | -3.516M |
| Cash from Financing (Quarterly) | -0.065M |
| Free Cash Flow Per Share (Quarterly) | -0.2288 |
| Free Cash Flow to Equity (Quarterly) | -15.37M |
| Free Cash Flow to Firm (Quarterly) | -15.84M |
| Free Cash Flow Yield | -48.76% |